Citation Impact
Citing Papers
Oxidative Stress
2017 Standout
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
2016 Standout
Cutting Edge: Distinct Glycolytic and Lipid Oxidative Metabolic Programs Are Essential for Effector and Regulatory CD4+ T Cell Subsets
2011 Standout
Increased omeprazole metabolism in carriers of the CYP2C19*17 allele; a pharmacokinetic study in healthy volunteers
2008
Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging
2023 Standout
Effects of sirolimus on plasma lipids, lipoprotein levels, and fatty acid metabolism in renal transplant patients
2002
An overview of clinical decision support systems: benefits, risks, and strategies for success
2020 Standout
A Retrospective Review of Liver Transplant Patients Treated with Sirolimus from a Single Center: An Analysis of Sirolimus-Related Complications
2004
Delayed gastric emptying (DGE) after pancreatic surgery: A suggested definition by the International Study Group of Pancreatic Surgery (ISGPS)
2007 Standout
St. John’s Wort – an Overview
2009 Standout
Molecular genetics and epigenetics of the cytochrome P450 gene family and its relevance for cancer risk and treatment
2009
Relative Contribution of CYP3A to Amitriptyline Clearance in Humans: In Vitro and In Vivo Studies
2001
Immunosuppressive drug monitoring - what to use in clinical practice today to improve renal graft outcome
2005
4β‐hydroxycholesterol, an endogenous marker of CYP3A4/5 activity in humans
2010
Chemical alterations taken place during deep-fat frying based on certain reaction products: A review
2012 Standout
mTOR Signaling in Growth Control and Disease
2012 Standout
Effects of the Antifungal Agents on Oxidative Drug Metabolism
2000
Pharmacogenetics of the Proton Pump Inhibitors: A Systematic Review
2003
Calcineurin Inhibitor Nephrotoxicity
2009 Standout
Pharmacogenetics and herb???drug interactions
2004
Polymorphism of human cytochrome P450 enzymes and its clinical impact
2009
Biomarkers of lipid peroxidation in clinical material
2013
Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease
2019 Standout
Cytochrome P-450 Polymorphisms and Response to Clopidogrel
2008 Standout
Pharmacokinetics of Ropivacaine in Uremic and Nonuremic Patients After Axillary Brachial Plexus Block
2003
Clinical Significance of the Cytochrome P450 2C19 Genetic Polymorphism
2002
Rapamycin, an mTOR inhibitor, disrupts triglyceride metabolism in guinea pigs
2006
St John’s wort extract (Ze 117) does not alter the pharmacokinetics of a low-dose oral contraceptive
2008
Rapamycin: One Drug, Many Effects
2014 Standout
Network pharmacology: the next paradigm in drug discovery
2008 Standout
Drug-Induced Hepatotoxicity
2003 Standout
Lipid peroxidation: Physiological levels and dual biological effects
2009
Continued superior outcomes with modification and lengthened follow-up of a steroid-avoidance pilot with extended daclizumab induction in pediatric renal transplantation1
2003
PROMISING EARLY OUTCOMES WITH A NOVEL, COMPLETE STEROID AVOIDANCE IMMUNOSUPPRESSION PROTOCOL IN PEDIATRIC RENAL TRANSPLANTATION1
2001
An Overview of Psychotropic Drug-Drug Interactions
2005
Kinetics of omeprazole and escitalopram in relation to the CYP2C19*17 allele in healthy subjects
2008
Influence of cytochrome P450 polymorphisms on drug therapies: Pharmacogenetic, pharmacoepigenetic and clinical aspects
2007
Sirolimus for Angiomyolipoma in Tuberous Sclerosis Complex or Lymphangioleiomyomatosis
2008 Standout
Postmarketing Surveillance
2011
Esomeprazole-induced healing of gastroesophageal reflux disease is unrelated to the genotype of CYP2C19: Evidence from clinical and pharmacokinetic data
2005
STEREOSELECTIVE METABOLISM OF LANSOPRAZOLE BY HUMAN LIVER CYTOCHROME P450 ENZYMES
2003
Inheritance and Drug Response
2003
Herbs and alternative therapies in the hypertension clinic
2001
The role of antioxidants in the chemistry of oxidative stress: A review
2015 Standout
Sirolimus changes lipid concentrations and lipoprotein metabolism in kidney transplant recipients
2003
Antioxidant therapy for treatment of inflammatory bowel disease: Does it work?
2015 Standout
Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation
2008
Clinical Pharmacokinetics and Pharmacodynamics of Tacrolimus in Solid Organ Transplantation
2004 Standout
Clinical Pharmacokinetics of Tacrolimus
1995 Standout
CYP2C19 Polymorphism and Proton Pump Inhibitors
2004
PTEN hamartoma tumor syndromes
2008 Standout
Tuberous sclerosis
2008 Standout
Metabolism of Antidepressant and Neuroleptic Drugs by Cytochrome P450s: Clinical and Interethnic Aspects
2007
Postoperative acute pancreatitis as a major determinant of postoperative delayed gastric emptying after pancreaticoduodenectomy
2006
Rapamycin Protects Against High Fat Diet–Induced Obesity in C57BL/6J Mice
2009
Prolonged Rapamycin Treatment Inhibits mTORC2 Assembly and Akt/PKB
2006 Standout
Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2
2009
Influence of Omeprazole on the Antiplatelet Action of Clopidogrel Associated With Aspirin
2008 Standout
Cholesterol-independent neuroprotective and neurotoxic activities of statins: Perspectives for statin use in Alzheimer disease and other age-related neurodegenerative disorders
2011
Normal and Pathologic Concentrations of Uremic Toxins
2012 Standout
CYP3A5 Genotype Has No Impact on Plasma Trough Concentrations of Lopinavir and Ritonavir in HIV-infected Subjects
2008
The mammalian target of rapamycin regulates lipid metabolism in primary cultures of rat hepatocytes
2007
AKT/PKB Signaling: Navigating the Network
2017 Standout
Herb-Drug Interactions
2005 Standout
Rifampicin is only a weak inducer of CYP1A2-mediated presystemic and systemic metabolism: studies with tizanidine and caffeine
2006
The PI3K Pathway in Human Disease
2017 Standout
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Immunotherapy in Elderly Transplant Recipients
2009
Effects of CYP2C19 Loss-of-Function Variants on the Eradication of H. pylori Infection in Patients Treated with Proton Pump Inhibitor-Based Triple Therapy Regimens: A Meta-Analysis of Randomized Clinical Trials
2013
International Consensus Recommendations on the Management of Patients With Nonvariceal Upper Gastrointestinal Bleeding
2010 Standout
Pharmacokinetics of Ropivacaine in Uremic and Nonuremic Patients After Axillary Brachial Plexus Block
2003
Phytosterol Oxidation Products: Their Formation, Occurrence, and Biological Effects
2009
Effect of Antiretroviral Therapy on Plasma Concentrations of Chloroquine and Desethyl-chloroquine
2018
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
National Rules for Drug–Drug Interactions: Are They Appropriate for Tertiary Hospitals?
2016
Heavy Metals and Human Health: Mechanistic Insight into Toxicity and Counter Defense System of Antioxidants
2015 Standout
Drug Therapy in the Heart Transplant Recipient
2005
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
U.S. Medical Eligibility Criteria for Contraceptive Use, 2016
2016 Standout
Omeprazole
2010
The Effect of Efavirenz on the Pharmacokinetics of An Oral Contraceptive Containing Ethinyl Estradiol and Norgestimate in Healthy HIV-Negative Women
2010
Pharmacogenetic testing among patients with mood and anxiety disorders is associated with decreased utilization and cost: A propensity-score matched study
2018 StandoutNobel
The TSC1–TSC2 complex: a molecular switchboard controlling cell growth
2008 Standout
Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements
2022
Molecular Docking: Challenges, Advances and its Use in Drug Discovery Perspective
2018 Standout
Review article: cytochrome P450 and the metabolism of proton pump inhibitors — emphasis on rabeprazole
1999
Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder
2008 Standout
Reactive Oxygen Species-Induced Lipid Peroxidation in Apoptosis, Autophagy, and Ferroptosis
2019 Standout
Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal
2014 Standout
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Fluorine in health care: Organofluorine containing blockbuster drugs
2010 Standout
Consenso colombiano de atención, diagnóstico y manejo de la infección por SARS-COV-2/COVID 19 en establecimientos de atención de la salud. Recomendaciones basadas en consenso de expertos e informadas en la evidencia
2020 Standout
Prescribed drugs containing nitrogen heterocycles: an overview
2020 Standout
Pharmacogenetics of Anti-HIV Drugs
2007
Resistant Hypertension: Diagnosis, Evaluation, and Treatment
2008 Standout
Works of Ylva Böttiger being referenced
4β‐Hydroxycholesterol as an endogenous marker for CYP3A4/5 activity. Stability and half‐life of elimination after induction with rifampicin
2008
Delayed gastric emptying and intestinal hormones following pancreatoduodenectomy
2005
CYP3A induction and inhibition by different antiretroviral regimens reflected by changes in plasma 4β-hydroxycholesterol levels
2008
Pharmacokinetic interaction between single oral doses of ditiazem and sirolimus in healthy volunteers*1
2001
Hypertriglyceridemia in renal transplant recipients treated with sirolimus
1998
Use of omeprazole sulfone in a single plasma sample as a probe for CYP3A4
2006
In vivo interconversion of 7β-hydroxycholesterol and 7-ketocholesterol, potential surrogate markers for oxidative stress
2007
CYP3A5 Genotype has an Impact on the Metabolism of the HIV Protease Inhibitor Saquinavir
2007
Metabolism of ropivacaine in humans is mediated by CYP1A2 and to a minor extent by CYP3A4: An interaction study with fluvoxamine and ketoconazole as in vivo inhibitors*
1998
Inhibition of the sulfoxidation of omeprazole by ketoconazole in poor and extensive metabolizers of S-mephenytoin*
1997
Drug related problems and off-label drug treatment in children as seen at a drug information centre
2006
Lamotrigine Drug Interactions in a TDM Material
1999
Effect of bile flow on the absorption of tacrolimus in liver allograft transplantation
2002
Enantioselective hydroxylation of omeprazole catalyzed by CYP2C19 in Swedish white subjects*
1997
Pronounced Differences in the Disposition of Clomipramine Between Japanese and Swedish Patients
1999
Cytochrome P450 Induction by Rifampicin in Healthy Subjects: Determination Using the Karolinska Cocktail and the Endogenous CYP3A4 Marker 4β-Hydroxycholesterol
2008
Involvement of CYP2D6 but not CYP2C19 in nicergoline metabolism in humans
1996
SFINX—a drug-drug interaction database designed for clinical decision support systems
2009
Adjuvant use of melatonin for pain management in dysmenorrhea — a randomized double-blinded, placebo-controlled trial
2021
134 TACROLIMUS (FK506) KINETICS IN LIVER AND KIDNEY TRANSPLANT RECIPIENTS
1995
[Drug-grapefruit interactions].
2007